4.7 Review

Therapeutic Manipulation of the HIF Hydroxylases

期刊

ANTIOXIDANTS & REDOX SIGNALING
卷 12, 期 4, 页码 481-501

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2009.2711

关键词

-

资金

  1. Biotechnology and Biological Sciences Research Council
  2. European Union
  3. Newton-Abraham Fund
  4. Wellcome Trust
  5. Medical Research Council
  6. Deutsche Forschungsgemeinschaft
  7. Medical Research Council [G0500495] Funding Source: researchfish
  8. National Institute for Health Research [ACF-2009-13-013] Funding Source: researchfish

向作者/读者索取更多资源

The hypoxia-inducible factor (HIF) family of transcription factors is responsible for coordinating the cellular response to low oxygen levels in animals. By regulating the expression of a large array of target genes during hypoxia, these proteins also direct adaptive changes in the hematopoietic, cardiovascular, and respiratory systems. They also play roles in pathological processes, including tumorogenesis. In recent years, several oxygenases have been identified as key molecular oxygen sensors within the HIF system. The HIF hydroxylases regulate the stability and transcriptional activity of the HIF-alpha subunit by catalyzing hydroxylation of specific proline and asparaginyl residues, respectively. They require oxygen and 2-oxoglutarate (2OG) as co-substrates, and depend upon non-heme ferrous iron (Fe(II)) as a cofactor. This article summarizes current understanding of the biochemistry of the HIF hydroxylases, identifies targets for their pharmacological manipulation, and discusses their potential in the therapeutic manipulation of the HIF system. Antioxid. Redox Signal. 12, 481-501.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据